Perkins Investment Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Perkins Investment Management's GILD Position: Q1 2017 in Review
Perkins Investment Management increased its Gilead Sciences (GILD) stake by 17% in Q1 2017, buying an estimated $63.3K and bringing the position to 6,200 shares worth $421K. The position accounts for 0.01% of the portfolio, ranked #229.
Perkins Investment Management first reported a position in GILD in Q2 2013 and has held it in 7 quarters since. The position peaked at $2.63M in Q2 2013. 1,525 funds tracked by Wall St. Rank hold GILD as of Q1 2017.
- Perkins Investment Management held 6,200 shares of Gilead Sciences worth $421K as of Q1 2017.
- Perkins Investment Management bought 900 Gilead Sciences shares in Q1 2017, an estimated $63.3K.
- Gilead Sciences made up 0.01% of Perkins Investment Management's portfolio in Q1 2017, its #229 holding.
- Perkins Investment Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 7 quarters since.
- Perkins Investment Management's Gilead Sciences position peaked at $2.63M in Q2 2013.
- 1,525 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2017.
Based on Perkins Investment Management's 13F filing for Q1 2017, filed 15 May 2017.